Update of results of autologous bone marrow transplantation in lymphoma

Keyphrases

• Transplantation 100%
• Lymphoma 100%
• Allogeneic Bone Marrow Transplantation 100%
• Patient Selection 66%
• Supportive Care 66%
• Non-Hodgkin Lymphoma 66%
• Hodgkin Disease 66%
• Bone Marrow Transplantation 66%
• Complete Remission 66%
• Hematopoietic Growth Factors 33%
• Initial Treatment 33%
• Mortality Rate 33%
• Marrow Transplantation 33%
• Prognostic Factors 33%
• High-dose Therapy 33%
• Preparative Regimen 33%
• North America 33%
• Large Series 33%
• Chemotherapy Regimen 33%
• Pretransplant 33%
• Transplant Registry 33%
• Refractory Lymphoma 33%
• Salvage Chemotherapy 33%
• Relapsed Lymphoma 33%
• Transplant-related Mortality 33%
• Long-term Disease-free Survival 33%
• Therapy Regimen 33%
• Under-five 33%

Medicine and Dentistry

• Bone Marrow Transplantation 100%
• Autologous Bone Marrow Transplantation 100%
• Transplantation 75%
• Supportive Care 50%
• Hodgkin's Lymphoma 50%
• Non-Hodgkin Lymphoma 50%
• Patient Selection 50%
• Hemopoietic Growth Factor 25%
• Drug Megadose 25%
• Mortality Rate 25%
• Emergency Medical Technician 25%
• Prognostic Factor 25%
• Disease Free Survival 25%
• Chemotherapy Regimens 25%

Immunology and Microbiology

• Bone Marrow Transplantation 100%
• Transplant Procedure 60%
• Drug Megadose 20%
• Mortality Rate 20%
• Disease Free Survival 20%
• Hemopoietic Growth Factor 20%